McIlrath & Eck’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.6K Hold
80
– – ﹤0.01% 559
2026
Q2
$12.7K Buy
+80
New +$10.8K ﹤0.01% 623
2025
Q1
– Sell
-70
Closed -$6.3K – 1009
2024
Q4
$6.3K Buy
+70
New +$6.78K ﹤0.01% 710

Other funds holding XBI

McIlrath & Eck's XBI Position: Q3 2026 in Review

McIlrath & Eck held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 80 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

McIlrath & Eck first reported a position in XBI in Q4 2024 and has held it in 3 quarters since. The position peaked at $12.7K in Q2 2026. 961 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • McIlrath & Eck held 80 shares of State Street SPDR S&P Biotech ETF worth $12.6K as of Q3 2026.
  • McIlrath & Eck left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of McIlrath & Eck's portfolio in Q3 2026, its #559 holding.
  • McIlrath & Eck first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 3 quarters since.
  • McIlrath & Eck's State Street SPDR S&P Biotech ETF position peaked at $12.7K in Q2 2026.
  • 961 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on McIlrath & Eck's 13F filing for Q3 2026, filed 17 Nov 2026.